Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2701 to 2715 of 9090 results

  1. Ruxuplam for treating Huntington's disease [TSID12429]

    Awaiting development Reference number: GID-TA12476 Expected publication date: TBC

  2. Blood-based biomarker tests for surveillance in people at risk of hepatocellular carcinoma: draft scope consultation

    We are listening to your views on this HealthTech guidance. Comments close 6 July 2026.

  3. Technologies for diagnosing endometriosis in primary care: early use assessment

    In development Reference number: GID-HTG10877 Expected publication date:  08 October 2026

  4. Oveporexton for treating type 1 narcolepsy [ID6622]

    In development Reference number: GID-TA11820 Expected publication date:  14 April 2027

  5. Digital platforms to support preparation before and rehabilitation after primary elective hip or knee replacement surgery: early-use assessment

    In development Reference number: GID-HTG10887 Expected publication date:  13 October 2026

  6. Middle meningeal artery embolisation for non-acute subdural haematomas

    In development Reference number: GID-HTG10869 Expected publication date:  19 November 2026

  7. Digital platforms to support preparation before and rehabilitation after primary elective hip or knee replacement surgery: early-use assessment: draft guidance

    We are listening to your views on this HealthTech guidance. Comments close 27 July 2026.

  8. Technologies for diagnosing endometriosis in primary care: early use assessment: draft guidance

    We are listening to your views on this HealthTech guidance. Comments close 27 July 2026.

  9. Middle meningeal artery embolisation for non-acute subdural haematomas: interventional procedure consultation

    We are listening to your views on this HealthTech guidance. Comments close 27 July 2026.

  10. Intrathecal onasemnogene abeparvovec for treating spinal muscular atrophy in people 2 years and over [ID6556]

    In development Reference number: GID-TA11733 Expected publication date:  26 August 2026

  11. Suspected sepsis: recognition, diagnosis and early management - procalcitonin testing: draft guidance consultation

    We are listening to your views on this NICE guideline. Comments close 10 July 2026.

  12. Headaches (update): Prophylactic treatment of migraine - Candesartan

    In development Reference number: GID-NG10472 Expected publication date: TBC

  13. Self-directed automated audiometry for the diagnosis of hearing loss in adults (provisional title)

    In development Reference number: GID-HTG10909 Expected publication date: TBC